AVDL logo

Avadel Pharmaceuticals (AVDL) Net income

annual net income:

-$48.83M+$111.44M(+69.53%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AVDL annual net profit is -$48.83 million, with the most recent change of +$111.44 million (+69.53%) on December 31, 2024.
  • During the last 3 years, AVDL annual net income has risen by +$28.50 million (+36.85%).
  • AVDL annual net income is now -171.53% below its all-time high of $68.27 million, reached on December 31, 2017.

Performance

AVDL Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

quarterly net income:

-$4.92M+$123.00K(+2.44%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AVDL quarterly net profit is -$4.92 million, with the most recent change of +$123.00 thousand (+2.44%) on March 31, 2025.
  • Over the past year, AVDL quarterly net income has increased by +$22.42 million (+82.01%).
  • AVDL quarterly net income is now -106.69% below its all-time high of $73.52 million, reached on December 31, 2015.

Performance

AVDL quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

TTM net income:

-$26.41M+$22.42M(+45.92%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AVDL TTM net profit is -$26.41 million, with the most recent change of +$22.42 million (+45.92%) on March 31, 2025.
  • Over the past year, AVDL TTM net income has increased by +$130.42 million (+83.16%).
  • AVDL TTM net income is now -132.50% below its all-time high of $81.25 million, reached on September 30, 2017.

Performance

AVDL TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

AVDL Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+69.5%+82.0%+83.2%
3 y3 years+36.9%+81.4%+70.8%
5 y5 years-47.0%-468.8%-25.3%

AVDL Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+69.5%-87.4%+92.4%at high+83.5%
5 y5-year-794.8%+69.5%-115.9%+92.4%-243.5%+83.5%
alltimeall time-171.5%+69.5%-106.7%+92.4%-132.5%+83.5%

AVDL Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$4.92M(-2.4%)
-$26.41M(-45.9%)
Dec 2024
-$48.83M(-69.5%)
-$5.04M(+92.1%)
-$48.83M(-32.7%)
Sep 2024
-
-$2.63M(-81.0%)
-$72.58M(-31.7%)
Jun 2024
-
-$13.82M(-49.4%)
-$106.22M(-32.3%)
Mar 2024
-
-$27.34M(-5.0%)
-$156.83M(-2.1%)
Dec 2023
-$160.28M(+16.6%)
-$28.79M(-20.6%)
-$160.28M(+0.8%)
Sep 2023
-
-$36.27M(-43.7%)
-$158.94M(+11.3%)
Jun 2023
-
-$64.43M(+109.3%)
-$142.81M(+0.7%)
Mar 2023
-
-$30.78M(+12.1%)
-$141.82M(+3.2%)
Dec 2022
-$137.46M(+77.8%)
-$27.45M(+36.3%)
-$137.46M(+3.9%)
Sep 2022
-
-$20.15M(-68.2%)
-$132.31M(-1.4%)
Jun 2022
-
-$63.44M(+140.1%)
-$134.17M(+48.6%)
Mar 2022
-
-$26.42M(+18.5%)
-$90.31M(+16.8%)
Dec 2021
-$77.33M(-1200.3%)
-$22.30M(+1.4%)
-$77.33M(+16.6%)
Sep 2021
-
-$22.00M(+12.4%)
-$66.31M(+18.4%)
Jun 2021
-
-$19.58M(+45.6%)
-$56.01M(+908.8%)
Mar 2021
-
-$13.45M(+19.2%)
-$5.55M(-179.0%)
Dec 2020
$7.03M(-121.2%)
-$11.28M(-3.6%)
$7.03M(-54.9%)
Sep 2020
-
-$11.70M(-137.9%)
$15.57M(-15.4%)
Jun 2020
-
$30.87M(-3669.2%)
$18.41M(-187.3%)
Mar 2020
-
-$865.00K(-68.4%)
-$21.07M(-36.6%)
Dec 2019
-$33.23M(-65.1%)
-$2.74M(-69.1%)
-$33.23M(-64.8%)
Sep 2019
-
-$8.86M(+3.0%)
-$94.35M(-6.8%)
Jun 2019
-
-$8.61M(-33.9%)
-$101.25M(+5.4%)
Mar 2019
-
-$13.02M(-79.6%)
-$96.09M(+0.8%)
Dec 2018
-$95.30M(-239.6%)
-$63.86M(+304.9%)
-$95.30M(+140.1%)
Sep 2018
-
-$15.77M(+358.7%)
-$39.69M(+1671.9%)
Jun 2018
-
-$3.44M(-71.9%)
-$2.24M(-107.4%)
Mar 2018
-
-$12.24M(+48.4%)
$30.13M(-55.9%)
Dec 2017
$68.27M(-265.4%)
-$8.24M(-138.0%)
$68.27M(-16.0%)
Sep 2017
-
$21.68M(-25.1%)
$81.25M(+105.3%)
Jun 2017
-
$28.93M(+11.6%)
$39.58M(-525.2%)
Mar 2017
-
$25.91M(+447.3%)
-$9.31M(-77.4%)
Dec 2016
-$41.28M(-198.8%)
$4.73M(-123.7%)
-$41.28M(-250.1%)
Sep 2016
-
-$19.99M(+0.2%)
$27.51M(+41.6%)
Jun 2016
-
-$19.96M(+229.4%)
$19.43M(-13.8%)
Mar 2016
-
-$6.06M(-108.2%)
$22.53M(-44.0%)
Dec 2015
$41.80M(-148.9%)
$73.52M(-361.9%)
$40.23M(-166.0%)
Sep 2015
-
-$28.07M(+66.5%)
-$61.00M(+42.0%)
Jun 2015
-
-$16.86M(-244.7%)
-$42.97M(-8.9%)
Mar 2015
-
$11.65M(-142.0%)
-$47.18M(-44.8%)
Dec 2014
-$85.47M(+99.1%)
-$27.71M(+175.9%)
-$85.47M(+62.4%)
Sep 2014
-
-$10.05M(-52.3%)
-$52.63M(+7.5%)
Jun 2014
-
-$21.07M(-20.9%)
-$48.95M(-19.4%)
Mar 2014
-
-$26.64M(-619.6%)
-$60.73M(+41.5%)
Dec 2013
-$42.92M(+1229.8%)
$5.13M(-180.5%)
-$42.92M(+10.2%)
Sep 2013
-
-$6.37M(-80.6%)
-$38.95M(-0.1%)
Jun 2013
-
-$32.85M(+272.1%)
-$39.01M(+223.2%)
Mar 2013
-
-$8.83M(-197.0%)
-$12.07M(+273.9%)
Dec 2012
-$3.23M(-63.2%)
$9.10M(-241.7%)
-$3.23M(-77.6%)
Sep 2012
-
-$6.42M(+8.6%)
-$14.42M(+129.2%)
Jun 2012
-
-$5.92M(<-9900.0%)
-$6.29M(+64.1%)
Mar 2012
-
$12.00K(-100.6%)
-$3.83M(-56.3%)
Dec 2011
-$8.77M(-2.2%)
-$2.09M(-222.8%)
-$8.77M(+119.1%)
Sep 2011
-
$1.70M(-149.2%)
-$4.00M(-55.7%)
Jun 2011
-
-$3.46M(-29.8%)
-$9.05M(-8.4%)
Mar 2011
-
-$4.93M(-284.0%)
-$9.88M(+10.1%)
Dec 2010
-$8.97M
$2.68M(-180.2%)
-$8.97M(-48.3%)
DateAnnualQuarterlyTTM
Sep 2010
-
-$3.34M(-22.2%)
-$17.35M(-0.2%)
Jun 2010
-
-$4.29M(+6.6%)
-$17.39M(+4.4%)
Mar 2010
-
-$4.02M(-29.4%)
-$16.65M(+45.6%)
Dec 2009
-$11.44M(-5.3%)
-$5.70M(+68.5%)
-$11.44M(+35.1%)
Sep 2009
-
-$3.38M(-4.7%)
-$8.47M(+14.6%)
Jun 2009
-
-$3.55M(-398.3%)
-$7.39M(+2.7%)
Mar 2009
-
$1.19M(-143.7%)
-$7.20M(-40.4%)
Dec 2008
-$12.08M(-68.0%)
-$2.73M(+18.3%)
-$12.08M(-21.0%)
Sep 2008
-
-$2.30M(-31.4%)
-$15.29M(-30.8%)
Jun 2008
-
-$3.36M(-9.1%)
-$22.10M(-31.7%)
Mar 2008
-
-$3.70M(-37.7%)
-$32.37M(-14.2%)
Dec 2007
-$37.74M(+7.2%)
-$5.94M(-34.8%)
-$37.74M(+0.2%)
Sep 2007
-
-$9.11M(-33.2%)
-$37.66M(-2.9%)
Jun 2007
-
-$13.63M(+50.5%)
-$38.77M(+12.0%)
Mar 2007
-
-$9.06M(+54.7%)
-$34.60M(-1.7%)
Dec 2006
-$35.20M(+28.6%)
-$5.86M(-42.7%)
-$35.20M(-1.7%)
Sep 2006
-
-$10.21M(+7.9%)
-$35.79M(-4.5%)
Jun 2006
-
-$9.47M(-2.0%)
-$37.46M(+0.6%)
Mar 2006
-
-$9.66M(+49.8%)
-$37.22M(+36.0%)
Dec 2005
-$27.38M(-319.0%)
-$6.45M(-45.7%)
-$27.38M(+110.5%)
Sep 2005
-
-$11.88M(+28.8%)
-$13.00M(-979.2%)
Jun 2005
-
-$9.23M(-5089.2%)
$1.48M(-83.1%)
Mar 2005
-
$185.00K(-97.7%)
$8.77M(-31.9%)
Dec 2004
$12.50M(-418.5%)
$7.93M(+205.1%)
$12.88M(+195.8%)
Sep 2004
-
$2.60M(-233.8%)
$4.35M(+4007.5%)
Jun 2004
-
-$1.94M(-145.2%)
$106.00K(-73.3%)
Mar 2004
-
$4.30M(-816.2%)
$397.00K(-107.1%)
Dec 2003
-$3.92M(-230.6%)
-$600.00K(-63.6%)
-$5.57M(+5.2%)
Sep 2003
-
-$1.65M(0.0%)
-$5.30M(+315.0%)
Jun 2003
-
-$1.65M(-1.4%)
-$1.28M(0.0%)
Mar 2003
-
-$1.67M(+411.6%)
-$1.28M(-502.8%)
Dec 2002
$3.00M(-204.6%)
-$327.00K(-113.8%)
$317.00K(-43.9%)
Sep 2002
-
$2.37M(-243.8%)
$565.00K(-122.8%)
Jun 2002
-
-$1.65M(+1988.6%)
-$2.47M(+13.3%)
Mar 2002
-
-$79.00K(0.0%)
-$2.18M(-24.0%)
Dec 2001
-$2.87M(-69.6%)
-$79.00K(-88.1%)
-$2.87M(-486.3%)
Sep 2001
-
-$666.00K(-51.0%)
$744.00K(+81.5%)
Jun 2001
-
-$1.36M(+76.9%)
$410.00K(-47.4%)
Mar 2001
-
-$769.00K(-121.7%)
$780.00K(-116.3%)
Dec 2000
-$9.46M(+41.3%)
$3.54M(-453.9%)
-$4.80M(-22.0%)
Sep 2000
-
-$1.00M(+1.0%)
-$6.15M(-24.2%)
Jun 2000
-
-$990.00K(-84.4%)
-$8.12M(-20.1%)
Mar 2000
-
-$6.35M(-390.4%)
-$10.16M(+51.3%)
Dec 1999
-$6.69M(-14.3%)
$2.19M(-173.7%)
-$6.72M(-36.1%)
Sep 1999
-
-$2.97M(-2.3%)
-$10.52M(+7.9%)
Jun 1999
-
-$3.04M(+4.7%)
-$9.75M(+17.3%)
Mar 1999
-
-$2.90M(+79.9%)
-$8.31M(+6.4%)
Dec 1998
-$7.81M(+14.9%)
-$1.61M(-26.7%)
-$7.81M(+28.1%)
Sep 1998
-
-$2.20M(+37.5%)
-$6.10M(-10.3%)
Jun 1998
-
-$1.60M(-33.3%)
-$6.80M(-8.1%)
Mar 1998
-
-$2.40M(-2500.0%)
-$7.40M(+10.4%)
Dec 1997
-$6.80M(-1.4%)
$100.00K(-103.4%)
-$6.70M(-20.2%)
Sep 1997
-
-$2.90M(+31.8%)
-$8.40M(+21.7%)
Jun 1997
-
-$2.20M(+29.4%)
-$6.90M(-2.8%)
Mar 1997
-
-$1.70M(+6.3%)
-$7.10M(+2.9%)
Dec 1996
-$6.90M
-$1.60M(+14.3%)
-$6.90M(+30.2%)
Sep 1996
-
-$1.40M(-41.7%)
-$5.30M(+35.9%)
Jun 1996
-
-$2.40M(+60.0%)
-$3.90M(+160.0%)
Mar 1996
-
-$1.50M
-$1.50M

FAQ

  • What is Avadel Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Avadel Pharmaceuticals?
  • What is Avadel Pharmaceuticals annual net income year-on-year change?
  • What is Avadel Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Avadel Pharmaceuticals?
  • What is Avadel Pharmaceuticals quarterly net income year-on-year change?
  • What is Avadel Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Avadel Pharmaceuticals?
  • What is Avadel Pharmaceuticals TTM net income year-on-year change?

What is Avadel Pharmaceuticals annual net profit?

The current annual net income of AVDL is -$48.83M

What is the all time high annual net income for Avadel Pharmaceuticals?

Avadel Pharmaceuticals all-time high annual net profit is $68.27M

What is Avadel Pharmaceuticals annual net income year-on-year change?

Over the past year, AVDL annual net profit has changed by +$111.44M (+69.53%)

What is Avadel Pharmaceuticals quarterly net profit?

The current quarterly net income of AVDL is -$4.92M

What is the all time high quarterly net income for Avadel Pharmaceuticals?

Avadel Pharmaceuticals all-time high quarterly net profit is $73.52M

What is Avadel Pharmaceuticals quarterly net income year-on-year change?

Over the past year, AVDL quarterly net profit has changed by +$22.42M (+82.01%)

What is Avadel Pharmaceuticals TTM net profit?

The current TTM net income of AVDL is -$26.41M

What is the all time high TTM net income for Avadel Pharmaceuticals?

Avadel Pharmaceuticals all-time high TTM net profit is $81.25M

What is Avadel Pharmaceuticals TTM net income year-on-year change?

Over the past year, AVDL TTM net profit has changed by +$130.42M (+83.16%)
On this page